Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-08-28
1998-07-07
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514221, A61K 3147
Patent
active
057769460
ABSTRACT:
Compounds which bind with high affinity to peripheral benzodiazepine receptors are useful as antiinflammatory agents. Such compounds include isoquinoline and benzodiazepine derivatives, such as PK 11195. A method of treating an inflammatory condition in a mammal with such compounds is provided. Pharmaceutical compositions comprising such compounds are provided. A method is provided for identifying compounds that are therapeutically effective for treating inflammatory conditions.
REFERENCES:
patent: 4788199 (1988-11-01), Benvides et al.
patent: 4788204 (1988-11-01), Benavides et al.
patent: 4808599 (1989-02-01), Dubroeucq et al.
patent: 5185442 (1993-02-01), Weber et al.
patent: 5192753 (1993-03-01), McGeer et al.
patent: 5488064 (1996-01-01), Sher
patent: 5550124 (1996-08-01), Gee
Bartlett et al., Development of Autoimmunity in MRL/1pr Mice and the Effects of Drugs on this Murine Disease, Scand J Rheumatol--Suppl 1988; 75:290-299.
Bessler et al., Immunomodulatory Effect of Peripheral Benzodiazepine Receptor Ligands on Human Mononuclear Cells, J Neurimmunol 1992; 38: 19-26.
Diorio et al., Peripheral Benzodiazepine Binding Sites in Alzheimer's Disease Frontal and Temporal Cortex, Neurobiol Aging 1991; 12: 255-258.
Doble et al., Labelling of Peripheral-type Benzodiazepine Binding Sites in Distribution,Brain Res Bull 1987; 18; 49-61.
Hayashi et al., Pathogenesis of Sjorgren's Syndrome-Like Autoimmune Lesions
Hirsch et al., Characterization of Ligand Binding to Mitochodrial Benzodiazepine Receptors, Mol Pharmacol 1989; 35: 164-172.
Junck et al., PET Imaging of Human Gliomas with Ligands for the Peripheral Benzodiazepine Binding Site, Ann Neurol 1989; 26 752-758.
Klegeris et al., Inhibiton of Respiratory Burst in Macrophages by Complement Receptor Blockade, Eur J Pharmacol 1994; 260: 273-277.
Koopman et al., The MRL-1pr Mouse. A Model for the Study of Rheumatoid
Lenfant et al., In vivo Immunomodulating Activity of PK 11195, a Structurally Unrelated Ligand for Peripheral Benzodiazepine Binding Sites. I. Potentiation in Mice of the Humoral Response to Sheep Red Blood Cells, Int. J. Immunopharmacol 1986; 8, 825-828.
Leong et al., Increased Densities of Binding Sites for the Regions of the Rat Brain in Thiamine Deficient Encephalopathy, J Cereb Blood Flow Metab 1994; 14: 100-105.
McGeer et al., Peripheral-type Benzodiazepine Binding in Alzeheimer Disease, Alz Dix Assoc Disorders 1988; 2: 331-336. 11195 Binding in Rat Cerebral Cortex Following a Local Ischaemic Lesion, J. Cerebral Blood Flow Metab 1991; 11: 314-322.
Ramsier et al., In vitro Inhibition of Cellular Immune Responses by Benzodiazepines and PK 11195, Immunopharmacol Immunotoxicol 1993; 15: 557-582.
Ratkay et al., Photodynamic Therapy: a Comparison with other Immunomodulatory Treatments of Adjuvant-enhanced Arthritis in MRL-1pr Mice, Clin Exp Immunol 1994; 95: 373-77.
Ratkay et al., Complete Freund's Adjuvant Induces an Earlier and More Severe Arthritis in MRL-1pr Mice, J Immunol 1993; 151:5081-5087.
Rosenberg, Neuromuscular Histopathology in (New Zealand Black .times. New Zealand White) F1 and MRL-1pr Autoimmune Mice: Models for Skeletal Muscle Involvement in Connective Tissue, Disease, Arthritis Rheumatism 1988; 31: 806-811.
Sakic et al., Brain-Reactive Antibodies and Behavior of Autoimmune MRL-1pr Mice, Physiol Behavior 1993; 54: 1025-1029. 5-4864 in Rat Brain and Kydney, J Pharm Exp Ther 1983; 225: 61-69.
Synder et al., Molecular Mechanism of Peripheral Benzodiazepine Recepators, Neurchem Res 1990; 15: 1992-123.
Vogelweid et al., Inflammatory Central Nervous System Disease in Lups-prone MRL/1pr Mice: Comparative histologic and Immunohistochemical findings, J Neuroimmunology 1991; 35; 89-99.
Zavala et al., Interaction of Benzodiazepines with Mouse Macrophages, Eur J Pharmac 1984; 106: 561-566.
Zavala et al., Peripheral Benzodiazepines Enhance the Respiratory Burst of Macrophage-Like P33D1 Cells Stimulated by Arachidonic Acid, Int J Neuropharmac 1987a; 9: 269-274.
Zavala et al., Benzodiazepines and PK 11195 Expert Immunomodulating Activities by Binding on a Specific Receptor on Macrophages, Ann NY Acad Sci 1987b; 496; 240-249.
Zisterer et al., The Effects of the Peripheral-Type Benzodiazepine Acceptor Ligand, Ro 5-4864 and PK 11195, on mitochondrial Respiration, Meth. Find. Clin. Pharmacol. 1992.
Klegeris et al., Rat Brain Microglia and Peritoneal Macrophages Show Similar Responses to Respiratory Burst Stimulants, J Neuroimmunology 1994; 53: 83-90.
Sprengel et al., Molecular Cloning and Expression of cDNA Encoding a Peripheral-Type Benzodiazepine Receptor, JBC 1989; 264(34): 20415-20421.
Parola et al. Cloning and Expression of a Pharmacologically Unique Bovine Peripheral-type Benzodiazepine Receptor Isoquinoline Binding Protein, JBC 1991; 266(21): 14082-14087.
Taketani et al., Induction of Peripheral-type Benzodiazepine Receptors during Differentiation of Mouse Erythroleukemia Cells, JBC 1994; 269(10): 7527-7531.
Toupin et al, Lymphokine & Cytokine Research, vol. 4 pp. 7-14 (1990).
McGeer Edith G.
McGeer Patrick L.
Waterfield J. Douglas
LandOfFree
Peripheral benzodiazepine receptor ligands as antiinflammatory a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peripheral benzodiazepine receptor ligands as antiinflammatory a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peripheral benzodiazepine receptor ligands as antiinflammatory a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1206219